Main Article Content
Breast cancer, Incidence, Mortality, Trends, Iran
Background: The present study aimed to investigate breast cancer trend, incidence, and mortality among Iranian women and was one of the first provincial and population-based studies to investigate breast cancer changes during 14 years in the largest province of Iran, Kerman.
Methods: This was a population-based longitudinal study. Information about women diagnosed with breast cancer from 2001 to 2014 was obtained from the Cancer Registry of Kerman University of Medical Sciences. Independent-samples t test, one-way analysis of variance, linear regression, time series graphs, and fitted line plots were performed using SPSS 22 and Minitab 17.
Results: A total of 2771 women were diagnosed with breast cancer in Kerman province from 2001 to 2014. The mean age of female patients was 49.52±12.88 years. The total incidence rate was 13.5 per 100,000 women and there was an increasing trend for incidence and age at diagnosis. Also, 254 women died from breast cancer during these 14 years and the mean mortality age was 54.16±14.33 years. There was also an increasing trend for mortality and age of death.
Conclusion: There is an increasing trend for incidence and mortality from breast cancer in Kerman province and this requires interventions such as appropriate screening programs. Also, enabling physicians and increasing patient awareness to identify breast cancer symptoms is necessary.
2. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology and Prevention Biomarkers. 2010;19(8):1893-907.
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015;136(5):E359-E86.
4. Harirchi I, Kolahdoozan S, Karbakhsh M, Chegini N, Mohseni S, Montazeri A, et al. Twenty years of breast cancer in Iran: downstaging without a formal screening program. Annals of oncology. 2011;22(1):93-7.
5. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet?Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87-108.
6. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology. 2016.
7. Ferlay J, Héry C, Autier P, Sankaranarayanan R. Global burden of breast cancer. Breast cancer epidemiology: Springer; 2010:1-19.
8. Ma J, Jemal A. Breast cancer statistics. Breast Cancer Metastasis and Drug Resistance: Springer; 2013:1-18.
9. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annals of Oncology. 2009;20(3):556-63.
10. Jazayeri SB, Saadat S, Ramezani R, Kaviani A. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer Epidemiol. 2015;39(4):519-27.
11. Vostakolaei FA, Broeders MJ, Rostami N, Van Dijck JA, Feuth T, Kiemeney LA, et al. Age at diagnosis and breast cancer survival in Iran. International journal of breast cancer. 2012;2012.
12. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. The breast journal. 2007;13(4):383-91.
13. AmericanCancerSociety. Breast Cancer Facts & Figures 2015-2016 [cited 2017 March 17]. Available from: [https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2015-2016.pdf]
14. Babu GR, Samari G, Cohen SP, Mahapatra T, Wahbe RM, Mermash S, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12(7):1647-55.
15. Vahdaninia M, Montazeri A. Breast cancer in Iran: a survival analysis. Asian pacific journal of cancer prevention. 2004;5(2):223-5.
16. Khanjani N, Noori A, Rostami F. The knowledge and practice of breast cancer screening among women in Kerman, Iran. Al-Ameen J Med Sci. 2012;5(2):221-6.
17. Asgarabad AA, Khanjani N, Saber M, Jalili S, Khedmati E. Knowledge and attitude of students at Alzahra University about breast self-examination, IRAN. Journal of Health and Development. 2012;1(2):112-0.
18. Rastad H, Khanjani N, Khandani BK. Causes of delay in seeking treatment in patients with breast cancer in Iran: a qualitative content analysis study. Asian Pacific Journal of Cancer Prevention. 2012;13(9):4511-5.
19. Sabbagh MQ, Khanjani N, Fadakar M, Iranpour A. Empowerment of women visiting the health centers of Kerman by teaching Self Breast Examination in the presence of Behvarz. Iranian Journal of Breast Disease. 2014;7(1):41-51 [persian].
20. Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, et al. Increased trend of breast cancer mortality in Iran. Asian Pacific Journal of Cancer Prevention. 2012;13(1):367-70.
21. Mehdi I, Monem EA, Al Bahrani BJ, Al Kharusi S, Nada AM, Al Lawati J, et al. Age at diagnosis of female breast cancer in Oman: Issues and implications. South Asian journal of cancer. 2014;3(2):101.
22. NationalCancerInstitute. Cancer Stat Facts: Female Breast Cancer. Available from: [https://seer.cancer.gov/statfacts/html/breast.html.]
23. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z. Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pacific Journal of Cancer Prevention. 2006;7(4):571.
24. Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer biology & medicine. 2014;11(2):101-15.
25. Mitchell K, Fritschi L, Reid A, McEvoy S, Ingram D, Jamrozik K, et al. Rural–urban differences in the presentation, management and survival of breast cancer in Western Australia. The Breast. 2006;15(6):769-76.
26. Armstrong T, Bonita R. Capacity building for an integrated noncommunicable disease risk factor surveillance system in developing countries. Ethnicity & disease. 2002;13(2 Suppl 2):S13-8.
27. Murray CJ, Lopez AD. Measuring the global burden of disease. New England Journal of Medicine. 2013;369(5):448-57.
28. Khazaei S, Rezaeian S, Khazaei Z, Molaeipoor L, Nematollahi S, Lak P, et al. National breast cancer mortality and incidence rates according to the human development index: an ecological Study. Advances in Breast Cancer Research. 2016;5(01):30.
29. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Héry C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. Bmj. 2010;341:c3620.
30. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2014. Annals of Oncology. 2014:138.